ArticlebioRxiv : the preprint server for biology2025
A structure-based modelling approach identifies effective drug combinations for RAS-mutant acute myeloid leukemia.
Luke Jones et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.